Madlen Witt

Research Scientist at Novaliq Gmbh

Madlen Witt's Professional Contact Details

Email (Verified)

****@novaliq.de

Get Email Address

Location

Heidelberg, Baden-WÃ¼rttemberg, Germany

Company

Novaliq Gmbh

Person Seniority

entry

Madlen Witt's Current Company Details

Novaliq Gmbh

Heidelberg, Baden-WÃ¼rttemberg, Germany • 29 Employees

pharmaceuticals

Novaliq GmbH, founded in 2007, is a specialty pharmaceutical company focused on the development of innovative water-free ophthalmics and located in the Heidelberg Technology Park, Germany. Our mission is to transform Active Pharmaceutical Ingredients (APIs) into highly effective ocular therapeutics for both the front and the back of the eye. NovaTearsÂ®, a first-in-class, water-free product with a novel mode of action for treatment of evaporative dry eye is registered and marketed in Europe. The most advanced Rx development is CyclASolÂ® for the treatment of moderate to severe dry eye disease. Recent reported phase 2 data confirmed that CyclASolÂ® has demonstrated a superior outcome and an earlier onset of action when compared head to head vs. Restasisâ„¢. All product developments are based on Novaliq's proprietary drug delivery technology called EyeSolÂ® which enhances the topical bio-availability, stability and safety of traditionally unstable APIs improving the delivery, efficacy and convenience of treatments for ocular surface diseases, including dry eye, through preservative free and multi dose formulations

Founded Year

2007

Organization Website

novaliq.com

Organization Languages

English, German

Organization Revenue

2400

Alexa Ranking

649273

Current Technologies

apache